Ownership history in Advisory Services Network, LLC · 6 quarters on record
This page tracks every 13F SEC filing in which Advisory Services Network, LLC reported a position in ULTRAGENYX PHARMACEUTICAL IN (RARE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 20 | +19 | +1900.0% | 0.00% | $602 | $30.08 |
| 2023 Q4 | UNCHANGED | 1 | — | 0% | 0.00% | $48 | $47.82 |
| 2023 Q1 | UNCHANGED | 1 | — | 0% | 0.00% | $40 | $40.10 |
| 2022 Q4 | REDUCED | 1 | -15 | -93.8% | 0.00% | $46 | $46.33 |
| 2020 Q3 | REDUCED | 16 | -9 | -36.0% | 0.00% | $1K | $82.19 |
| 2019 Q4 | INITIATED | 25 | — | — | 0.00% | $1K | $42.71 |
As of 2025 Q4 — sorted by position size